Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day
Journal of Thrombosis and Haemostasis · 2024-01 · 22 (1) · 255-262
DOI: 10.1016/j.jtha.2023.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-01. Verfasst von Sara A Malerba und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Angiology, University Hospital Zurich, Zurich, Switzerland; Department of Medicine, University Hospital of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Venous Thromboembolism, Thrombosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
BACKGROUND: Data on availability, affordability, and accessibility is key for the planning of global strategies to reduce the burden of venous thromboembolism (VTE). OBJECTIVES: A survey was conducted for the 10th anniversary of World Thrombosis Day to assess the availability of VTE therapies worldwide and challenges in uniform implementation. METHODS: We gathered information on the approval status, availability, utilization, occurrence of shortages, and spread of medical and interventional therapies for VTE. Furthermore, we collected information by accessing or contacting national or continental medicines agencies, manufacturers or distributors, and online drug repositories. RESULTS: We obtained data from a total of 69 countries: 33 countries in Europe, 19 in Asia, 7 in the Americas, 9 in Africa, and 1 in Oceania. Unfractionated heparin, low-molecular-weight heparin, and vitamin K antagonists were available in almost all countries, but shortages were recorded in 13%, 19%, and 15% of them, respectively. Direct oral anticoagulants were available in approximately three-quarters of the surveyed countries. At least one parenteral medication for heparin-induced thrombocytopenia was available in 57% of countries and a shortage was reported in 9% of these. Shortage of thrombolytics was recorded in 50% of countries. Overall, at least one type of catheter-directed therapy system was approved for use in 77% of countries and available in 23% of surveyed institutions. Our findings revealed notable geographic disparities in the worldwide availability of VTE therapies, the access to which appeared to be limited by economic and geopolitical factors. CONCLUSION: We anticipate that this comprehensive information will play a pivotal role in highlighting the shortcomings of VTE therapies and the lack of homogeneous availability globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Angiology, University Hospital Zurich, Zurich, Switzerland; Department of Medicine, University Hospital of Padua, Padua, Italy.
- Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
- Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
- Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico.
- School of Medical Sciences, University of Campinas, Campinas, Brazil; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil.
- Department of Cardiovascular Surgery, Florence Nightingale Atasehir Hospital, Istanbul, Turkey.
Zitieren
APA
Malerba, S. A., Fumagalli, R. M., Ay, C., Cesarman-Maus, G., De Paula, E. V., Dumantepe, M., Guillermo Esposito, M. C., Hobohm, L., Sadeghipour, P., Samama, C. M., Sartori, M. T., Castellucci, L. A., Barco, S., & World Thrombosis Day Steering Committee (2024). Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day. Journal of Thrombosis and Haemostasis, 22(1), 255-262. https://doi.org/10.1016/j.jtha.2023.10.002
Vancouver
Malerba SA, Fumagalli RM, Ay C, Cesarman-Maus G, De Paula EV, Dumantepe M, et al. Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day. Journal of Thrombosis and Haemostasis. 2024;22(1):255-262. doi:10.1016/j.jtha.2023.10.002
BibTeX
@article{Malerba2024,
author = {Malerba, Sara A and Fumagalli, Riccardo M and Ay, Cihan and Cesarman-Maus, Gabriela and De Paula, Erich V and Dumantepe, Mert and Guillermo Esposito, Maria Cecilia and Hobohm, Lukas and Sadeghipour, Parham and Samama, Charles M and Sartori, Maria Teresa and Castellucci, Lana A and Barco, Stefano and World Thrombosis Day Steering Committee, World Thrombosis Day Steering Committee},
title = {Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
volume = {22},
number = {1},
pages = {255--262},
doi = {10.1016/j.jtha.2023.10.002}
}
EUVIMED